Business

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and...

U2Fx.comU2Fx.com
Mar 11, 2026 - 14:00
 0  15
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and...
Read More

Tags:

Previous Article

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Resu...

Next Article

Easterly Asset Management to buy Olstein fund business

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

In memoriam: Nicholas 'Nick' Xavier Kuehn, junior, Pamplin College of Business

In memoriam: Nicholas 'Nick' Xavier Kuehn, junior, Pamp...

U2Fx.com Apr 16, 2026  0  11

Mason restaurant closing after years of business citing rent hikes

Mason restaurant closing after years of business citing...

U2Fx.com Dec 2, 2025  0  19

AI adoption risks now top concerns for US business leaders: Vistra

AI adoption risks now top concerns for US business lead...

U2Fx.com Nov 27, 2025  0  18